B2B SaaS: 2026 Valuation Multiples 25 Feb 2026 Exit, Investment, Tech, Valuation - While B2B SaaS Revenue Multiples saw a slight recovery in 2024 to 6.7x, they contracted again in 2025, settling at 5.9x.
Lessons From The UK’s Top 50 Exits 12 Nov 2025 Exit, Trends - The most successful founders are those who build a company to be bought, not sold.
SEG’s 2025 Report Reveals SaaS M&A Metrics & Benchmarks 21 Feb 2025 Exit, Trends - This report includes metrics and benchmarks that SaaS M&A players on the buy side consider essential for investment and exit opportunities.
UK & Ireland Reclaim EMEA Top Spot In M&A Activity 27 Nov 2024 Exit, Trends - After a sub-par performance in the first half of 2024, more companies in UK & Ireland have been the target of M&A deals.
Introduction to Employee Ownership Trusts 16 May 2024 Exit, Leadership, Strategy, Tax, Trends - EOTs becoming a popular exit or succession planning strategy.
CyberSecurity: 2024 Valuation Multiples 9 Mar 2024 Exit, Investment, Tech, Valuation - Revenue multiples showed a slight upward trajectory throughout last year, eventually reaching 7.3x in Q4 2023.
FinTech: 2024 Valuation Multiples 26 Jan 2024 Exit, Investment, Tech, Valuation - Last year saw an ever-so-slight gain in FinTech revenue multiples, growing from 5x in Q1 2023 to 6.3x in Q4 2023.
What is a tax indemnity? 17 Jan 2024 Exit, Strategy - A tax indemnity protects the buyer from unexpected liabilities that are revealed after the sale is completed.
Thinking Ahead with Your Exit Plan: Key Considerations Before Exiting Your Business 28 Nov 2023 Exit, Strategy - Creating a long-term strategy and planning ahead can maximise the value of your business.
What is the Difference Between an Asset Sale and a Share Sale? 21 Nov 2023 Exit, Strategy, Tax, Valuation - The main difference between an asset sale and a share sale is that in a share sale, the buyer will acquire all the company’s responsibilities.
Ariceum Therapeutics has acquired Theragnostics 14 Jul 2023 Clients, Exit - Congratulations from Finerva to all Theragnostics team regarding a successful Exit!
Interview with Peter Mountney, CEO of Odin Vision 6 Jun 2023 Clients, Exit, Opinion, Success Stories - Recently, Odin Vision was acquired by Olympus, a leading global Med Tech company.








